Incorporated under the laws of the state of Utah on November 27, 1996 and reincorporated in Delaware on July 31, 2007 Zars Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using their proprietary drug delivery technologies (CHADD, Peel, Durapeel), primarily in the area of pain management. Their main products Pliaglis, Synera and ThermoProfen. In 2007 Company announced that have not generated any revenues from commercial sales of products and have not been profitable.

Company was acquired by Nuvo Research, Inc.